CASE DISMISSED! Lawsuit against FDA over SSRI warning label is thrown out
The case - dismissed on a technicality of standing - enables the FDA to disregard its own legal obligations and evade accountability for its inaction on citizen petitions.
A lawsuit against the U.S. Food and Drug Administration (FDA) has been dismissed, highlighting the difficulty of holding federal agencies accountable.
The case focused on the FDA’s failure to update antidepressant warning labels to alert patients and doctors about Post-SSRI Sexual Dysfunction (PSSD), a serious condition that can persist long after stopping the medication.
Despite legal action, the court ruled that the plaintiff lacked “standing,” hence, they were not entitled to bring a case against the FDA in federal court.
